Spots Global Cancer Trial Database for lung scc
Every month we try and update this database with for lung scc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung | NCT05228795 | Lung Cancer Ade... Lung Cancer Squ... Mesothelioma; L... | - | Sohag University | ||
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | NCT01351103 | Pancreatic Canc... BRAF Mutant Col... Melanoma Triple Negative... Head and Neck S... Cervical Squamo... Esophageal Squa... Lung Squamous C... | LGK974 PDR001 | 18 Years - | Novartis | |
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung | NCT05228795 | Lung Cancer Ade... Lung Cancer Squ... Mesothelioma; L... | - | Sohag University | ||
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | NCT01351103 | Pancreatic Canc... BRAF Mutant Col... Melanoma Triple Negative... Head and Neck S... Cervical Squamo... Esophageal Squa... Lung Squamous C... | LGK974 PDR001 | 18 Years - | Novartis |